Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

Phase 1 Completed 40 enrolled European Organisation for Research and Treatment of Cancer - EORTC

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of ecteinascidin 743 in treating adults with advanced solid tumors.

Timeline

Start: 1996-02
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Trabectedin	Small molecule	—	Intravenous

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

Summary

Timeline

Drugs

Indications